… transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete …
S Yu, F Huang, Y Wang, Y Xu, T Yang, Z Fan, R Lin… - Leukemia, 2020 - nature.com
… -versus-host disease and relapse free survival were 63 and … if they were chronic myelogenous
leukemia with blast crisis or … All188 evaluable patients achieved full donor chimerism on …
leukemia with blast crisis or … All188 evaluable patients achieved full donor chimerism on …
[HTML][HTML] … , and antithymocyte globulin for hematopoietic cell transplantation from unrelated or haploidentical family donors in patients with acute myeloid leukemia in …
KH Lee, JH Lee, JH Lee, DY Kim, HS Park… - … Marrow Transplantation, 2017 - Elsevier
… from transplantation to recurrence, NRM, or last follow-up. … failed to achieve >90% donor
chimerism at 1 months after HCT, … an independent predictor of leukemia recurrence. After AML …
chimerism at 1 months after HCT, … an independent predictor of leukemia recurrence. After AML …
Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia
MQ Salas, S Prem, EG Atenafu, AD Law… - European Journal of …, 2019 - Wiley Online Library
… was defined as loss of donor chimerism (<5% donor cells) after initial … interest were overall
survival (OS), relapse-free survival (RFS… Donor type was a significant predictor for RFS on the …
survival (OS), relapse-free survival (RFS… Donor type was a significant predictor for RFS on the …
[HTML][HTML] … settings after allogeneic transplantation for hematologic malignancies are associated with high five-year survival if persistent full donor chimerism is obtained …
LE Caldemeyer, LP Akard, JR Edwards… - … Marrow Transplantation, 2017 - Elsevier
… cell transplantation (HSCT), is a predictor of disease relapse. … with a superior 5-year
progression-free survival (PFS) of 71% … relapsed chronic myeloid leukemia (CML) by inducing …
progression-free survival (PFS) of 71% … relapsed chronic myeloid leukemia (CML) by inducing …
Donor Lymphocyte Infusions' Efficacy in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: A Single Center Long-Term Analysis
D Mallouri, I Sakellari, E Gavriilaki… - … of Blood and Marrow …, 2017 - tctjournal.org
… persistent mixed chimerism (MC) is a known predictor of high … % donor chimerism in PB (n
= 13). We analyzed age, gender, … One-year post DLIs Disease-free survival (DFS) was 50% …
= 13). We analyzed age, gender, … One-year post DLIs Disease-free survival (DFS) was 50% …
… -alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
M Maschan, L Shelikhova, M Ilushina… - … marrow transplantation, 2016 - nature.com
… in mixed chimerism in the CD34+ fraction or bone marrow therapeutic donor lymphocyte …
-free survival (EFS), relapse-free survival (RFS) and OS. For EFS, death from any cause and …
-free survival (EFS), relapse-free survival (RFS) and OS. For EFS, death from any cause and …
A practical guide to chimerism analysis: review of the literature and testing practices worldwide
AG Blouin, F Ye, J Williams, M Askar - Human immunology, 2021 - Elsevier
… Mixed chimerism (MC) is defined by identifying both donor … In 2001, the International Bone
Marrow Transplant Registry (… and longer relapse free survival but not overall survival than …
Marrow Transplant Registry (… and longer relapse free survival but not overall survival than …
[HTML][HTML] … FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
… significant improvements in both relapse-free survival (RFS) and … in complete remission
with full donor chimerism, with 1-year … indicator for allogeneic transplantation in acute myeloid …
with full donor chimerism, with 1-year … indicator for allogeneic transplantation in acute myeloid …
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft‐versus‐host disease and survival outcome
Y Akahoshi, S Kimura, A Gomyo… - Hematological …, 2018 - Wiley Online Library
… malignancy, chronic myelogenous leukaemia in chronic phase, … donor chimerism might
lead to a low incidence of chronic … , information regarding chimerism following HSCT was not …
lead to a low incidence of chronic … , information regarding chimerism following HSCT was not …
… /BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation
T Ueda, T Maeda, S Kusakabe, J Fujita… - International Journal of …, 2019 - Springer
… The 4-year overall survival and disease-free survival rates … patients, including 33 with acute
myeloid leukemia (AML) and 9 … transplantation to promote complete donor-type chimerism, …
myeloid leukemia (AML) and 9 … transplantation to promote complete donor-type chimerism, …